Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping review.


Journal

Primary health care research & development
ISSN: 1477-1128
Titre abrégé: Prim Health Care Res Dev
Pays: England
ID NLM: 100897390

Informations de publication

Date de publication:
15 11 2022
Historique:
entrez: 15 11 2022
pubmed: 16 11 2022
medline: 18 11 2022
Statut: epublish

Résumé

The aim of this study is to review the literature in Commonwealth of Independent States (CIS) countries with regard to their response to non-communicable diseases (NCDs) and the implementation of the World Health Organization (WHO) Package of Essential Non-communicable (PEN) disease interventions for primary health care. NCDs are estimated to account from 62% to 92% of total deaths in CIS countries. Current management of NCDs in CIS countries is focused on specialists and hospital care versus primary health care (PHC) as recommended by the WHO. This paper uses a scoping review of published and grey literature focusing on diabetes and hypertension in CIS countries. These two conditions are chosen as they represent a large burden in CIS countries and are included in the responses proposed by the WHO PEN. A total of 96 documents were identified and analysed with the results presented using the WHO Health System Building Blocks. Most of the publications identified focused on the service delivery (41) and human resources (20) components, while few addressed information and research (17), and only one publication was related to medical products. As for their disease of focus, most studies focused on hypertension (14) and much less on diabetes (3). The most studies came from Russia (18), followed by Ukraine (21) and then Kazakhstan (12). Only two countries Moldova and Kyrgyzstan have piloted the WHO PEN. Overall, the studies identified highlight the importance of the PHC system to better control and manage NCDs in CIS countries. However, these present only strategies versus concrete interventions. One of the main challenges is that NCD care at PHC in CIS countries continues to be predominantly provided by specialists in addition to focusing on treatment versus preventative services.

Sections du résumé

AIM
The aim of this study is to review the literature in Commonwealth of Independent States (CIS) countries with regard to their response to non-communicable diseases (NCDs) and the implementation of the World Health Organization (WHO) Package of Essential Non-communicable (PEN) disease interventions for primary health care.
BACKGROUND
NCDs are estimated to account from 62% to 92% of total deaths in CIS countries. Current management of NCDs in CIS countries is focused on specialists and hospital care versus primary health care (PHC) as recommended by the WHO.
METHODS
This paper uses a scoping review of published and grey literature focusing on diabetes and hypertension in CIS countries. These two conditions are chosen as they represent a large burden in CIS countries and are included in the responses proposed by the WHO PEN.
FINDINGS
A total of 96 documents were identified and analysed with the results presented using the WHO Health System Building Blocks. Most of the publications identified focused on the service delivery (41) and human resources (20) components, while few addressed information and research (17), and only one publication was related to medical products. As for their disease of focus, most studies focused on hypertension (14) and much less on diabetes (3). The most studies came from Russia (18), followed by Ukraine (21) and then Kazakhstan (12). Only two countries Moldova and Kyrgyzstan have piloted the WHO PEN. Overall, the studies identified highlight the importance of the PHC system to better control and manage NCDs in CIS countries. However, these present only strategies versus concrete interventions. One of the main challenges is that NCD care at PHC in CIS countries continues to be predominantly provided by specialists in addition to focusing on treatment versus preventative services.

Identifiants

pubmed: 36377062
pii: S1463423622000639
doi: 10.1017/S1463423622000639
pmc: PMC9706385
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e73

Références

Int J Hypertens. 2012;2012:951734
pubmed: 23251790
Georgian Med News. 2009 Jul-Aug;(172-173):96-9
pubmed: 19644201
Soc Sci Med. 2014 Aug;114:57-65
pubmed: 24911509
Collegian. 2009;16(1):35-40
pubmed: 19388425
Wiad Lek. 2018;71(2 pt 2):331-334
pubmed: 29786581
BMC Health Serv Res. 2014 Sep 30;14:446
pubmed: 25269470
Wiad Lek. 2018;71(3 pt 2):728-732
pubmed: 29783257
Vestn Ross Akad Med Nauk. 2013;(2):4-11
pubmed: 23819322
London J Prim Care (Abingdon). 2008;1(2):81-4
pubmed: 25949564
PLoS One. 2017 Oct 24;12(10):e0186745
pubmed: 29065147
Cent Asian J Glob Health. 2014 Sep 29;3(1):186
pubmed: 29755891
Ter Arkh. 2015;87(1):4-9
pubmed: 25823263
Eur J Prev Cardiol. 2019 May;26(8):824-835
pubmed: 30739508
BMC Health Serv Res. 2013 Mar 18;13:103
pubmed: 23505990
Glob Health Sci Pract. 2017 Sep 28;5(3):412-429
pubmed: 28963174
Wiad Lek. 2014;67(2 Pt 2):298-301
pubmed: 25796853
PLoS One. 2020 Apr 21;15(4):e0231899
pubmed: 32315357
Bull World Health Organ. 2015 Jan 1;93(1):9-10
pubmed: 25558102
J Glob Health. 2019 Jun;9(1):010316
pubmed: 31217953
Health Policy Plan. 2002 Sep;17(3):264-72
pubmed: 12135992
Br J Gen Pract. 2015 Jun;65(635):308-9
pubmed: 26009520
Health Syst Transit. 2014;16(5):1-137, xiii
pubmed: 25689490
Lancet. 2013 Mar 30;381(9872):1145-55
pubmed: 23541055
Risk Manag Healthc Policy. 2018 Nov 02;11:209-220
pubmed: 30464661
BMC Fam Pract. 2017 Aug 22;18(1):80
pubmed: 28830385
J Community Health. 2013 Dec;38(6):1132-9
pubmed: 23824876
BMJ Open. 2019 Jul 4;9(7):e025705
pubmed: 31278091
Cardiovasc Diagn Ther. 2019 Apr;9(2):129-139
pubmed: 31143634
Wiad Lek. 2018;71(4):897-906
pubmed: 30099432
Global Health. 2017 Mar 15;13(1):16
pubmed: 28298226
Bull World Health Organ. 2014 Jan 1;92(1):10-19C
pubmed: 24391296
Turk Kardiyol Dern Ars. 2014 Sep;42(6):545-52
pubmed: 25362945
Georgian Med News. 2017 Jan;(262):116-120
pubmed: 28252441
Health Serv Res. 2012 Apr;47(2):840-64
pubmed: 22092004
Health Policy Plan. 2013 Aug;28(5):458-66
pubmed: 22987825
Bull World Health Organ. 2016 Nov 1;94(11):792-793
pubmed: 27821881
Wiad Lek. 2020;73(3):454-456
pubmed: 32285812
J R Soc Med. 2017 Sep;110(9):365-375
pubmed: 28895493
Eur J Gen Pract. 2013 Dec;19(4):261-5
pubmed: 23971996
Wiad Lek. 2019 Aug 31;72(8):1532-1541
pubmed: 32012505
Front Pharmacol. 2019 Nov 19;10:1375
pubmed: 31824316
Wiad Lek. 2016;69(2 Pt 2):183-9
pubmed: 27487531
Wiad Lek. 2016;69(6):719-725
pubmed: 28214802
Fam Med. 2007 Oct;39(9):627-33
pubmed: 17932795
PLoS One. 2015 Jul 08;10(7):e0127199
pubmed: 26154083
Wiad Lek. 2019;72(5 cz 1):938-941
pubmed: 31175800
Iran J Public Health. 2014 Dec;43(12):1695-701
pubmed: 26171363
Georgian Med News. 2017 Mar;(264):53-57
pubmed: 28480850
Public Health. 2009 Nov;123(11):725-8
pubmed: 19889431
Wiad Lek. 2019;72(1):107-111
pubmed: 30796873
BMC Fam Pract. 2012 Mar 12;13:15
pubmed: 22409775
PLoS One. 2020 May 29;15(5):e0233801
pubmed: 32470073
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2016 Mar-Apr;24(2):98-101
pubmed: 29553209
Prim Health Care Res Dev. 2020 Sep 30;21:e39
pubmed: 32993832
BMJ Glob Health. 2018 Oct 24;3(Suppl 3):e000992
pubmed: 30498594
Bull World Health Organ. 2005 Dec;83(12):920-7
pubmed: 16462984
Wiad Lek. 2017;70(3 pt 1):433-438
pubmed: 28711883
Ter Arkh. 2013;85(8):8-13
pubmed: 24137958
BMC Health Serv Res. 2019 Jun 4;19(1):353
pubmed: 31164125
Cent Asian J Glob Health. 2015 Apr 08;4(1):209
pubmed: 29138716
Wiad Lek. 2018;71(9):1753-1758
pubmed: 30737935
PLoS One. 2019 Apr 22;14(4):e0215636
pubmed: 31009496
Lancet Glob Health. 2020 Apr;8(4):e511-e523
pubmed: 32199120
BMC Fam Pract. 2013 Mar 19;14:37
pubmed: 23510461
Hypertension. 2013 Jul;62(1):18-26
pubmed: 23670299
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2017 Jul;25(4):216-220
pubmed: 29510010

Auteurs

Elvira Muratalieva (E)

Biomedical Sciences Global Health Track at the University of Geneva, Genève, Switzerland.
Swiss Development and Cooperation in the Kyrgyz Republic and Embassy of Switzerland in the Kyrgyz Republic, 21 Erkindik boulevard, Bishkek720040, Kyrgyzstan.

Mathieu Nendaz (M)

Medical Education Development and Research Unit (UDREM), Department of General Internal Medicine, Faculty of Medicine, Université de Genève, 1211Genève 4, Switzerland.

David Beran (D)

Division of Tropical and Humanitarian Medicine, Geneva University Hospitals and Université de Genève, 1211Genève 4, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH